UPDATE 1-Agile Therapeutics exploring funding options after FDA meeting

May 18 (Reuters) - Agile Therapeutics Inc said on Friday it is looking for ways to fund operations after U.S. health regulators suggested that a new clinical trial may be required to test the company's stick-on contraceptive patch.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.